HPV cfDNA is a highly effective tumor marker for monitoring disease progression and treatment response in HPV-positive cervical cancer, offering valuable insights for guiding clinical decisions in ...

Rising Merkel cell polyomavirus oncoprotein antibody titers predict a 58% recurrence risk at 12 months, while falling or ...

9-week non-invasive blood test deciphers each twin’s sex chromosomes, giving expectant mothers worldwide clarity without ...

To make the behavior of DNA understandable and predictable, the researchers combine lab experiments with computer simulations ...

A CRISPR mouth-swab test could transform TB screening with rapid, low-cost detection in low-resource and asymptomatic cases.

The conviction integrity unit is reviewing new DNA and child services reports in Joel Terry’s case, a pivotal test for Lucas ...

PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous ...

Aging, neurological diseases and our bodies' stress response are all linked to the tiny power plants inside each cell known ...

According to Precedence Research, the global liquid biopsy market size will grow from USD 7.05 billion in 2025 to nearly USD ...

(NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the activation of the NRG Oncology trial, ARCHER (NRG-GU015), a randomized, phase III study in muscle-invasive ...

Fetal Signal Assessment: Utilizes whole-genome SNP scanning to confirm fetal signal presence, precisely quantify fetal ...

Researchers explore DNA methylation patterns for early ovarian cancer detection, aiming to improve survival rates through ...